Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, CXCR4 | 1 | 2021 | 727 | 0.550 |
Why?
|
Multiple Myeloma | 6 | 2024 | 5146 | 0.510 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2024 | 2825 | 0.450 |
Why?
|
Neoplastic Stem Cells | 3 | 2021 | 1347 | 0.450 |
Why?
|
Autocrine Communication | 1 | 2013 | 169 | 0.420 |
Why?
|
Aquaporins | 1 | 2013 | 174 | 0.410 |
Why?
|
Esophageal Neoplasms | 3 | 2016 | 1654 | 0.380 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 487 | 0.350 |
Why?
|
Epithelium | 1 | 2014 | 1603 | 0.340 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2021 | 5305 | 0.340 |
Why?
|
Cell Division | 1 | 2016 | 4465 | 0.320 |
Why?
|
Ion Channels | 1 | 2013 | 1040 | 0.310 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7594 | 0.290 |
Why?
|
Cell Lineage | 5 | 2024 | 2555 | 0.280 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.260 |
Why?
|
Stem Cells | 2 | 2014 | 3522 | 0.230 |
Why?
|
Cell Differentiation | 2 | 2016 | 11528 | 0.190 |
Why?
|
Cell Proliferation | 2 | 2016 | 10445 | 0.190 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13639 | 0.180 |
Why?
|
Galectins | 1 | 2021 | 295 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 651 | 0.150 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 382 | 0.140 |
Why?
|
Mutation | 5 | 2021 | 30052 | 0.130 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4876 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2022 | 940 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8547 | 0.130 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3877 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4758 | 0.110 |
Why?
|
Clone Cells | 2 | 2014 | 1659 | 0.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1551 | 0.110 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2449 | 0.110 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1745 | 0.100 |
Why?
|
Drug Resistance, Multiple | 1 | 2013 | 255 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4511 | 0.100 |
Why?
|
Signal Transduction | 2 | 2024 | 23445 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 16981 | 0.080 |
Why?
|
Esophagus | 1 | 2014 | 1033 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9539 | 0.070 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Animals | 6 | 2024 | 168459 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3802 | 0.050 |
Why?
|
Humans | 14 | 2024 | 761504 | 0.040 |
Why?
|
Germinal Center | 1 | 2022 | 380 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2022 | 424 | 0.040 |
Why?
|
Optometry | 1 | 1978 | 29 | 0.040 |
Why?
|
Societies | 1 | 1978 | 108 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3272 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58976 | 0.030 |
Why?
|
Treatment Failure | 1 | 2022 | 2645 | 0.030 |
Why?
|
Paris | 1 | 2014 | 41 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2200 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6132 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2547 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 1640 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3602 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1469 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 29625 | 0.020 |
Why?
|
Aged | 2 | 2021 | 169289 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2057 | 0.020 |
Why?
|
Female | 3 | 2021 | 392644 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 220895 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2014 | 743 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7396 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39106 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13506 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4740 | 0.020 |
Why?
|
Male | 2 | 2021 | 360804 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5671 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18252 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10194 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9280 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81525 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22176 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5796 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36192 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42230 | 0.010 |
Why?
|
Persuasive Communication | 1 | 1978 | 58 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12128 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59243 | 0.010 |
Why?
|
Child | 1 | 2021 | 80153 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88319 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39967 | 0.010 |
Why?
|
Motivation | 1 | 1978 | 2006 | 0.000 |
Why?
|
Adult | 1 | 2021 | 221177 | 0.000 |
Why?
|
United States | 1 | 1978 | 72334 | 0.000 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_